1.1100
25-نوفمبر-24 13:10:06
15 متأخرة بدقائق
الأسهم
+0.0300
+2.78%
نطاق اليوم
1.0600 - 1.1200
ISIN
N/A
المصدر
NASDAQ
Clearside Biomedical Announces First Patients Enrolled in Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD
12 يناير 2021 07:05:00 بحسب Nasdaq GlobeNewswire
Clearside Biomedical Announces Pricing of $12 Million Registered Direct Offering
06 يناير 2021 07:05:00 بحسب Nasdaq GlobeNewswire